AU Patent

AU2021282405A1 — Multi-unit drug delivery devices and methods

Assigned to Taris Biomedical LLC · Expires 2021-12-23 · 4y expired

What this patent protects

A drug formulation comprising: at least 75% by weight gemcitabine HCl; urea; and at least one pharmaceutical lubricant.

USPTO Abstract

A drug formulation comprising: at least 75% by weight gemcitabine HCl; urea; and at least one pharmaceutical lubricant.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021282405A1
Jurisdiction
AU
Classification
—
Expires
2021-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Taris Biomedical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.